首页> 外文期刊>British Journal of Haematology >Advances in understanding the pathogenesis of primary familial and congenital polycythaemia
【24h】

Advances in understanding the pathogenesis of primary familial and congenital polycythaemia

机译:了解原发性家族性和先天性红细胞增多症的发病机制

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Primary familial and congenital polycythemia (PFCP) is an autosomal-dominant proliferative disorder characterized by erythrocytosis and hypersensitivity of erythroid progenitors to erythropoietin (Epo). Several lines of evidence suggest a causal role of truncated erythropoietin receptor (EpoR) in this disease. In this review, we discuss PFCP in the context of erythrocytosis and EpoR signalling. We focus on recent studies describing mechanisms underlying Epo-dependent EpoR down-regulation. One mechanism depends on internalization mediated through the p85 regulatory subunit of the Phospho-inositide 3-Kinase, and the other utilizes ubiquitin-based proteasomal degradation. Truncated PFCP EpoRs are not properly down-regulated upon stimulation, underscoring the importance of these mechanisms in the pathogenesis of PFCP.
机译:原发性家族性和先天性红细胞增多症(PFCP)是常染色体显性增生性疾病,其特征在于红细胞增多症和红系祖细胞对促红细胞生成素(Epo)的超敏性。几条证据表明,促红细胞生成素受体(EpoR)截断在该疾病中起因果作用。在这篇综述中,我们讨论了红细胞增多症和EpoR信号传导的背景下的PFCP。我们专注于描述潜在的Epo依赖EpoR下调的机制的最新研究。一种机制取决于通过磷酸肌醇3-激酶的p85调节亚基介导的内在化,而另一种机制则利用了基于泛素的蛋白酶体降解。刺激后,截短的PFCP EpoR并未适当下调,从而强调了这些机制在PFCP发病机理中的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号